With HPMC-based hard capsules, dose form can play a huge role in creating a finished drug product that delivers a more specific therapeutic performance and achieves the desired patient outcomes.
Following on from the first part of a discussion in oral solid dose trends, our vice president Brad Gold speaks alongside a panel of pharma leaders on the topic of patient centricity.
Discover the factors that are at the forefront of industry-leader’s minds in the full article.
